hVIVO plc (AIM: HVO), the pioneer of human challenge models of disease, is pleased to announce that its Annual Report and Financial Statements for the year ended 31 December 2014 is being posted to shareholders today. It will be available on the Company’s website (http://hvivo.com/investors/financial-reports/) from 4.30 pm today.
For further information please contact:
hVIVO plc +44 207 756 1300
Kym Denny (Chief Executive Officer)
Graham Yeatman (Chief Financial & Business Officer)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
Notes to Editors:
hVIVO plc (“hVIVO”) is a life sciences company pioneering a technology platform of human disease models to accelerate drug development and discovery in respiratory and infectious diseases. Based in the UK, hVIVO has conducted over 40 clinical studies, involving more than 1950 volunteers for a range of leading industry, governmental and academic clients.